Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saireito is a traditional Japanese Kampo medicine composed of a standardized combination of two other formulas: Shosaikoto (Minor Bupleurum Decoction) and Goreisan (Five-Ingredient Powder with Poria). It is widely utilized in Japan for its immunomodulatory, anti-inflammatory, and diuretic properties, particularly in the management of inflammatory conditions associated with fluid imbalance. The formula consists of 12 medicinal herbs, including Bupleurum root, Alisma rhizome, and Scutellaria root. Saireito is frequently employed as a steroid-sparing agent in the treatment of renal diseases such as nephrotic syndrome and IgA nephropathy, as well as for gastroenteritis and edema. Its mechanism of action involves the suppression of pro-inflammatory cytokines like TNF-α and IL-6, and the regulation of water homeostasis through the modulation of aquaporin-2 expression in the kidneys.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saireito.